According to the new report published by Absolute Markets Insights (AMI), the global microbial cell banking market is growing at a CAGR of 14.45% during the forecast period of 2021-2030. AMI anticipates that the market will grow as the demand for microbial cell banking has increased. The microbial cell banking market players are dependent primarily on research and development which is helping them in improving the current models to maintain competitiveness in the market.

Master Cell Banking to Grow at the Fastest Rate over the Forecast Period (2021-2030)

According to Absolute Market Insights report, the master cell banking cell line accounted for the highest market share in 2020 and is expected to remain the fastest-growing segment during the 2021-2030 period in the global microbial cell banking market. The development in the field of biopharmaceutical market is helping in the production of bio drugs. One of the main steps for the production of therapeutic protein is dependent on a system of bacterial expression which is usually extracted from cells. So, to maintain the homogeneity and quality of the initial inoculum constantly, microbial cell banks need to be created with quality standards. Initially, cell banks must focus on the establishment of the Master Cell Banks (MCB), which is needed for the development of working cell banks (WCB). Working cell banks which are derived from the master cell banks are usually used to establish seed cultures of the cell line which helps in initiating the manufacturing process of several drugs and proteins that are used for the treatment of diseases. Cell banks are used to generate characterization of cell lines which are helpful in mitigating the chances of cross-contamination of cell lines. Thus, these factors are creating demand for the growth of master cell banking market.

Access the Full Article @ https://www.industryglobalnews24.com/find-out-what-are-the-important-factors-boosting-the-demand-of-global-microbial-cell-banking-market-

Growth in the Demand for High-Quality Cell Substrates

High-quality cell substrates are used in the development and manufacturing of biologics. The high quality of biologics is totally dependent on the quality of cell substrates used. So there is growth in demand for these high-quality cell substrates which is driving the growth of microbial cell banking market. Furthermore, rapid advancements in the field of microbiology and pharmaceuticals have increased the usage of cell substrates in the treatment of various infectious and contagious diseases. There has been a drastic rise in research activities after the COVID - 19 pandemic to address the unmet medical needs in the field of healthcare by biopharmaceuticals. Moreover, increasing problems of gene variability and contamination during the production processes have leveraged the adoption of microbial cell banking. Furthermore, rapid development in the field of microbiology has increased the demand for cell substrates in the treatment of serious medical ailments which helps in boosting the market demand among end-users. All these factors are potential drivers that are leading for the growth of the microbial cell banking market.

Asia Pacific region to Grow at the Fastest Rate over the Forecast Period (2021-2030)

AMI reports that Asia Pacific region will grow at the fastest rate over the forecast period as the population in major countries like China continues to age, and opportunities for commercialization is steadily increasing. Furthermore, large population of the region and expanding access to healthcare are driving new avenues for growth of players in the microbial cell banking market in the future. Increasing researches and rapid growth in the biotechnology and pharmaceutical industries are few other factors driving the growth in this region. The outbreak of Covid-19 has also prompted the government to increase the pace of vaccine development. The development of new vaccines and medicines is going to offer lucrative opportunities for the players in this region. The increase in healthcare expenditure in the Asia Pacific region is also boosting the market growth of microbial cell banking market.

Some of the players operating in the global microbial cell banking market include Eurofins Scientific; Vibalogics GmbH; Lonza Group Ltd.; Merck KGaA; Luina Bio; Altogen Labs; Biovian Oy; VGXI, Inc.; ATCC and Charles River Laboratories, Inc.

Global Microbial Cell Banking Market

By Microbial Cell Line

  • Master Cell Bank (MCB)
  • Working Cell Bank (WCB)
  • End of Product Cells (EOPC)
  • Others

By Species

  • Bacteria
  • Viruses
  • Cell Lines
  • Fungi and Yeast
  • Others

By Testing Type

  • Culture Viability
  • Strain Identity
  • Genetic Stability
  • Purity Testing
  • Use Testing

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutions
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin Americ

Contact Us:

Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com